-
OraSure Technologies Announces New Co-Promotion Agreement for OraQuick HCV Rapid Antibody Test
OraSure Technologies (Nasdaq:OSUR) announced that it has entered into an agreement with AbbVie to co-promote the Company’s OraQuick® HCV Rapid Test. The product will be used to test individuals at-risk for hepatitis C (HCV). “We believe it is critical that at-risk individuals be tested for hepatitis C to prevent serious consequences from untreated infection,” said Continue Reading…
Daily Archives:
June 18th, 2014
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.